Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BPTH | US
-0.01
-1.28%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
0.87
0.90
0.90
0.87
Bio-Path Holdings Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize a drug delivery and antisense technology platform that uses P-ethoxy which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 (BP1002) for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 (BP1003) for the treatment of pancreatic cancer non-small cell lung cancer and AML; and BP1001-A for the treatment of solid tumors. Bio-Path Holdings Inc. was founded in 2007 and is based in Bellaire Texas.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
57.1%1 month
65.1%3 months
78.5%6 months
132.1%-
-
1.83
0.04
0.01
0.03
-
-
-12.98M
2.22M
2.22M
-
-
-
-
-366.18
0.02
0.64
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.14
Range1M
0.20
Range3M
1.17
Rel. volume
0.18
Price X volume
12.19K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
PRFX | PRFX | Drug Manufacturers-Specialty & Generic | 0.6413 | 791.65K | 4.68% | n/a | -2.89% |
Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.103 | 0 | -0.96% | n/a | 2.46% |
Biofrontera Inc. Warrants | BFRIW | Drug Manufacturers-Specialty & Generic | 0.02 | 0 | n/a | 13.20% | |
Alvotech Warrant | ALVOW | Drug Manufacturers-Specialty & Generic | 2.98 | 0 | n/a | -196.14% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4859 | 2.44M | -9.19% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 913.02K | -1.96% | n/a | -37.05% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.17 | 0 | 0.78% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.03 | 17.21 | Cheaper |
Ent. to Revenue | - | 334.38 | - |
PE Ratio | - | 26.92 | - |
Price to Book | 1.83 | 12.15 | Cheaper |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 78.52 | 68.34 | Par |
Debt to Equity | 0.04 | -1.00 | Expensive |
Debt to Assets | 0.01 | 0.48 | Cheaper |
Market Cap | 2.22M | 5.31B | Emerging |